全文获取类型
收费全文 | 35178篇 |
免费 | 1266篇 |
国内免费 | 645篇 |
专业分类
耳鼻咽喉 | 601篇 |
儿科学 | 817篇 |
妇产科学 | 437篇 |
基础医学 | 1027篇 |
口腔科学 | 524篇 |
临床医学 | 2890篇 |
内科学 | 4328篇 |
皮肤病学 | 557篇 |
神经病学 | 1948篇 |
特种医学 | 845篇 |
外科学 | 5261篇 |
综合类 | 6495篇 |
预防医学 | 2026篇 |
眼科学 | 536篇 |
药学 | 4154篇 |
50篇 | |
中国医学 | 2238篇 |
肿瘤学 | 2355篇 |
出版年
2024年 | 11篇 |
2023年 | 414篇 |
2022年 | 1063篇 |
2021年 | 1246篇 |
2020年 | 1217篇 |
2019年 | 1025篇 |
2018年 | 999篇 |
2017年 | 904篇 |
2016年 | 1050篇 |
2015年 | 1119篇 |
2014年 | 3028篇 |
2013年 | 2856篇 |
2012年 | 2641篇 |
2011年 | 2892篇 |
2010年 | 2502篇 |
2009年 | 2038篇 |
2008年 | 1896篇 |
2007年 | 1749篇 |
2006年 | 1453篇 |
2005年 | 1220篇 |
2004年 | 1032篇 |
2003年 | 947篇 |
2002年 | 771篇 |
2001年 | 698篇 |
2000年 | 474篇 |
1999年 | 364篇 |
1998年 | 287篇 |
1997年 | 181篇 |
1996年 | 145篇 |
1995年 | 111篇 |
1994年 | 99篇 |
1993年 | 74篇 |
1992年 | 57篇 |
1991年 | 46篇 |
1990年 | 41篇 |
1989年 | 34篇 |
1988年 | 38篇 |
1987年 | 32篇 |
1986年 | 26篇 |
1985年 | 67篇 |
1984年 | 41篇 |
1983年 | 29篇 |
1982年 | 24篇 |
1981年 | 16篇 |
1980年 | 37篇 |
1979年 | 28篇 |
1978年 | 10篇 |
1977年 | 7篇 |
1974年 | 7篇 |
1972年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Salvatore Greco Beatrice Bonsi Nicol Fabbri 《World Journal of Experimental Medicine》2022,12(5):104-107
Even if the relationships between nutrition and inflammatory bowel disease (IBD) remain underexplored, the current literature is providing, day by day, much more evidence on the effects of various diets in both prevention and treatment of such illnesses. Wrong dietary habits, together with other environmental factors such as pollution, breastfeeding, smoke, and/or antibiotics, are among the theoretical pathogenetic causes of IBD, whose multifactorial aetiology has been already confirmed. While some of these risk factors are potentially reversible, some others cannot be avoided, and efficient treatments become necessary to prevent IBD spread or recurrence. Furthermore, the drugs currently available for treatment of such disease provide low-to-no effect against the symptoms, making the illnesses still strongly disabling. Whether nutrition and specific diets will prove to effectively interrupt the course of IBD has still to be clarified and, in this sense, further research concerning the applications of such dietary interventions is still needed. 相似文献
2.
3.
4.
5.
6.
《European journal of surgical oncology》2022,48(5):1104-1109
BackgroundThis study aimed to describe the treatment of metachronous colorectal cancer metastases in a recent population-based cohort.MethodPatients with stage I-III colorectal cancer (CRC), diagnosed between January 1st and June 30th, 2015 who were surgically treated with curative intent were selected from the Netherlands Cancer Registry. Follow-up was at least 3 years after diagnosis of the primary tumour. Treatment of metachronous metastases was categorized into local treatment, systemic treatment, and best supportive care. Overall survival was estimated using Kaplan-Meier method.ResultsOut of 5412 patients, 782 (14%) developed metachronous metastases, of whom 393 (50%) underwent local treatment (LT) with or without systemic therapy, 30% of patients underwent only systemic therapy (ST) and 19% only best supportive care (BSC). The most common metastatic site was the liver (51%) followed by lungs (33%) and peritoneum (22%). LT rates were 69%, 66%, and 44% for liver-only, lung-only and, peritoneal-only metastases respectively. Patients receiving LT and ST were significantly younger than patients receiving LT alone, while patients receiving BSC were significantly older than the other groups (p < 0.001). Patients with liver-only or lung-only metastases had a 3-year OS of 50.2% (43.3–56.7 95% CI) and 61.5% (50.7–70.6 95% CI) respectively. Patients with peritoneal-only disease had a lower 3-year OS, 18.1% (10.1–28.0 95% CI).ConclusionPatients with metastases confined to the liver and lung have the highest rates of local treatment for metachronous metastatic colorectal cancer. The number of patients who underwent local treatment is higher than reported in previous Dutch and international studies. 相似文献
7.
8.
背景难治性高血压是一种特殊类型的高血压,病因复杂,治疗难度大,更易引起靶器官损害。近年研究发现,在难治性高血压患者三联常用降压药物治疗基础上添加小剂量螺内酯能有效控制血压。但这些研究规模普遍较小,其有效性与安全性尚需进一步验证。目的系统评价螺内酯治疗难治性高血压的疗效及安全性。方法计算机检索PubMed、Web of Science、The Cochrane Library、中国知网、维普网、万方数据知识服务平台,筛选螺内酯治疗难治性高血压的随机对照研究,检索时间为建库至2021-05-03。由2名研究员独立筛选文献、提取资料并评价纳入研究的偏倚风险后,采用RevMan 5.3软件进行Meta分析。结果共纳入20项研究。9项研究未报告随机化分组方法,1项研究按纳入顺序编号奇偶分配(错误的随机化方法),7项研究未描述是否采用盲法,4项研究为开放标签,3项研究描述了分配隐藏,1项研究结果数据不完整、未报告对照组治疗后的安全性指标。Meta分析结果显示,疗效方面:与安慰剂和空白对照相比,螺内酯降低诊室血压、24 h动态血压、日间血压及夜间血压的效果好(P<0.05);与其他降压药物总体相比,螺内酯降低诊室收缩压、24 h动态血压、日间收缩压、夜间收缩压及家庭自测收缩压的效果好(P<0.05);与肾脏去交感神经术相比,螺内酯降低日间血压及夜间收缩压的效果好(P<0.05)。安全性方面:与安慰剂相比,应用螺内酯患者的血钾及血肌酐水平高(P<0.05);与其他降压药物总体相比,应用螺内酯患者的血钾水平升高(P<0.05);与肾脏去交感神经术相比,应用螺内酯患者的血肌酐水平升高(P<0.05)。结论螺内酯治疗难治性高血压是相对有效及安全的,但受纳入研究数量和质量的限制,该结论尚需更多高质量研究予以证实。 相似文献
9.
10.
ObjectiveTo investigate the feasibility of transnasal heated humidified high flow nasal cannula oxygen therapy (HFNC) in the treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) with respiratory failure in elderly patients. MethodsA total of 176 elderly patients with AECOPD complicated with respiratory failure who were hospitalized at Peking University Shougang Hospital from December 2016 to January 2022 were enrolled, including 82 patients in an HFNC group and 94 patients in an NPPV group. After treatment, pulse oxygen saturation (SPO2), arterial partial pressure of carbon dioxide (PaCO2), oxygenation index (OI), respiratory rate (RR), heart rate (HR), mean arterial pressure (MAP), comfort score, discharge rate, rate of endotracheal intubation, rate of transfer to intensive care unit (ICU), and mortality were compared between the two groups. The independent sample t-test was used for comparison between the two groups. Statistical data are expressed in percentage or number of cases and the χ2 test was used for their comparisons. ResultsThe SPO2 values at 30 min, 1 h, and 6 h were significantly higher in the HFNC group than in the NPPV group (t=-2.049,-2.618, and -3.314, P=0.043, 0.010, and 0.001, respectively). SPO2 before discharge was significantly lower than that of the NPPV group (t=2.162, P=0.033), but OI at each time point and before discharge had no statistical significance (P>0.05). MAP at 6 h was significantly higher in the HFNC group than in the NPPV group (t=-2.209, P=0.029), but within the normal range. HRs at 2 h and 3 h in the HFNC group were significantly higher than those of the NPPV group (t=-2.199 and -2.336, P=0.030 and 0.021, respectively). There were no significant differences in RR, HR, or MAP between the two groups at other time points and before discharge (P>0.05). There was no significant difference in PaCO2 between the two groups (P>0.05). Comfort score in the HFNC group was significantly higher than that of the NPPV group (t=-46.807, P<0.001). There were no significant differences in discharge rate, ICU transfer rate, endotracheal intubation rate, and mortality between the two groups (P>0.05). ConclusionHFNC is as effective as NPPV in treating elderly patients with AECOPD complicated with type Ⅰ or mild type Ⅱ respiratory failure, and HFNC is more comfortable than NPPV. 相似文献